ANI Pharmaceuticals ANIP Return on equity

Return on equity at other companies

Amneal Pharmaceuticals, Inc.AMRX

-52.8%-12.7pp

ViatrisVTRS

-2.8%-1.3pp

AnaptysBio, Inc.ANAB

-343.8%-1,012pp

ALN

Alnylam PharmaceuticalsALNY

91.4%—

Eton Pharmaceuticals, Inc.ETON

-34.2%+0.9pp

Aurinia PharmaceuticalsAUPH

66.1%+48.8pp

FAQ

What is ANI Pharmaceuticals's return on equity?

ANI Pharmaceuticals (ANIP) reported return on equity of 21% in Q2 2026.

How has ANI Pharmaceuticals's return on equity changed year-over-year?

ANI Pharmaceuticals's return on equity increased by 1015.5% year-over-year, from -2.3% to 21%.

What is the long-term trend for ANI Pharmaceuticals's return on equity?

Over 5 years (2020 to 2025), ANI Pharmaceuticals's return on equity has grown at a 8.5% compound annual growth rate (CAGR), from -11% to 16.6%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.